Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06428396
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-05-20
Brief Title:
Study of Belzutifan MK-6482 Plus Fulvestrant for ERHER2- Metastatic Breast Cancer MK-6482-029LITESPARK-029
Sponsor:
Organization:
Merck Sharp Dohme LLC